Myelofibrosis-Associated Lymphoproliferative Disease: Retrospective Study of 16 Cases and Literature Review

Background. To better describe the clinical, biological, and the outcome of non-Hodgkin's lymphoma (NHL) with, at the initial presentation, bone marrow fibrosis (MF). Patients and Methods. From January 2001 to January 2007, 16 eligible patients with NHL and MF were retrieved from the Pathology...

Full description

Saved in:
Bibliographic Details
Main Authors: A. Etienne, B. Gruson, D. Chatelain, R. Garidi, B. Royer, H. Sevestre, J. P. Marolleau, G. Damaj
Format: Article
Language:English
Published: Wiley 2009-01-01
Series:Advances in Hematology
Online Access:http://dx.doi.org/10.1155/2009/179847
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832556345391316992
author A. Etienne
B. Gruson
D. Chatelain
R. Garidi
B. Royer
H. Sevestre
J. P. Marolleau
G. Damaj
author_facet A. Etienne
B. Gruson
D. Chatelain
R. Garidi
B. Royer
H. Sevestre
J. P. Marolleau
G. Damaj
author_sort A. Etienne
collection DOAJ
description Background. To better describe the clinical, biological, and the outcome of non-Hodgkin's lymphoma (NHL) with, at the initial presentation, bone marrow fibrosis (MF). Patients and Methods. From January 2001 to January 2007, 16 eligible patients with NHL and MF were retrieved from the Pathology Department of the University hospital of Amiens. Median age of patients was 62 years (range 16–74) with a sex ratio male/female of 3. Results. MF is associated with all types of lymphoma predominantly with B-cell phenotype and it seems to be more associated with low-grade NHL. B-symptoms are more frequent at diagnosis and more patients presented with an elevated LDH level. JAK-2 was negative in the 10 patients analysed. Two patients presented with features of primary MF with no evidence of lymphoma. Overall response rate was 94% after the first line of therapy with regression or improvement of MF. Relapse occurred in 8 patients (47%) with recurrence of MF in all of them. After a median follow-up of 42 months, 12 patients were alive with an overall survival rate for the entire group of 75%. Conclusions. MF-associated NHL is a rare manifestation which may be associated with all types of NHL and its presence does not seem to confer a poor prognosis. A search for lymphoproliferation should be considered when the cause of MF is not apparent.
format Article
id doaj-art-897b98d8d54049b788299b5edb4f1036
institution Kabale University
issn 1687-9104
1687-9112
language English
publishDate 2009-01-01
publisher Wiley
record_format Article
series Advances in Hematology
spelling doaj-art-897b98d8d54049b788299b5edb4f10362025-02-03T05:45:39ZengWileyAdvances in Hematology1687-91041687-91122009-01-01200910.1155/2009/179847179847Myelofibrosis-Associated Lymphoproliferative Disease: Retrospective Study of 16 Cases and Literature ReviewA. Etienne0B. Gruson1D. Chatelain2R. Garidi3B. Royer4H. Sevestre5J. P. Marolleau6G. Damaj7Department of Clinical Hematology, Centre Hospitalier Universitaire, University Hospital of Amiens, 1 Place Victor Pauchet, 80000 Amiens, FranceDepartment of Clinical Hematology, Centre Hospitalier Universitaire, University Hospital of Amiens, 1 Place Victor Pauchet, 80000 Amiens, FranceDepartment of Clinical Pathology, University Hospital of Amiens, 1 Place Victor Pauchet, 80000 Amiens, FranceDepartment of Clinical Hematology, Centre Hospitalier Universitaire, University Hospital of Amiens, 1 Place Victor Pauchet, 80000 Amiens, FranceDepartment of Clinical Hematology, Centre Hospitalier Universitaire, University Hospital of Amiens, 1 Place Victor Pauchet, 80000 Amiens, FranceDepartment of Clinical Pathology, University Hospital of Amiens, 1 Place Victor Pauchet, 80000 Amiens, FranceDepartment of Clinical Hematology, Centre Hospitalier Universitaire, University Hospital of Amiens, 1 Place Victor Pauchet, 80000 Amiens, FranceDepartment of Clinical Hematology, Centre Hospitalier Universitaire, University Hospital of Amiens, 1 Place Victor Pauchet, 80000 Amiens, FranceBackground. To better describe the clinical, biological, and the outcome of non-Hodgkin's lymphoma (NHL) with, at the initial presentation, bone marrow fibrosis (MF). Patients and Methods. From January 2001 to January 2007, 16 eligible patients with NHL and MF were retrieved from the Pathology Department of the University hospital of Amiens. Median age of patients was 62 years (range 16–74) with a sex ratio male/female of 3. Results. MF is associated with all types of lymphoma predominantly with B-cell phenotype and it seems to be more associated with low-grade NHL. B-symptoms are more frequent at diagnosis and more patients presented with an elevated LDH level. JAK-2 was negative in the 10 patients analysed. Two patients presented with features of primary MF with no evidence of lymphoma. Overall response rate was 94% after the first line of therapy with regression or improvement of MF. Relapse occurred in 8 patients (47%) with recurrence of MF in all of them. After a median follow-up of 42 months, 12 patients were alive with an overall survival rate for the entire group of 75%. Conclusions. MF-associated NHL is a rare manifestation which may be associated with all types of NHL and its presence does not seem to confer a poor prognosis. A search for lymphoproliferation should be considered when the cause of MF is not apparent.http://dx.doi.org/10.1155/2009/179847
spellingShingle A. Etienne
B. Gruson
D. Chatelain
R. Garidi
B. Royer
H. Sevestre
J. P. Marolleau
G. Damaj
Myelofibrosis-Associated Lymphoproliferative Disease: Retrospective Study of 16 Cases and Literature Review
Advances in Hematology
title Myelofibrosis-Associated Lymphoproliferative Disease: Retrospective Study of 16 Cases and Literature Review
title_full Myelofibrosis-Associated Lymphoproliferative Disease: Retrospective Study of 16 Cases and Literature Review
title_fullStr Myelofibrosis-Associated Lymphoproliferative Disease: Retrospective Study of 16 Cases and Literature Review
title_full_unstemmed Myelofibrosis-Associated Lymphoproliferative Disease: Retrospective Study of 16 Cases and Literature Review
title_short Myelofibrosis-Associated Lymphoproliferative Disease: Retrospective Study of 16 Cases and Literature Review
title_sort myelofibrosis associated lymphoproliferative disease retrospective study of 16 cases and literature review
url http://dx.doi.org/10.1155/2009/179847
work_keys_str_mv AT aetienne myelofibrosisassociatedlymphoproliferativediseaseretrospectivestudyof16casesandliteraturereview
AT bgruson myelofibrosisassociatedlymphoproliferativediseaseretrospectivestudyof16casesandliteraturereview
AT dchatelain myelofibrosisassociatedlymphoproliferativediseaseretrospectivestudyof16casesandliteraturereview
AT rgaridi myelofibrosisassociatedlymphoproliferativediseaseretrospectivestudyof16casesandliteraturereview
AT broyer myelofibrosisassociatedlymphoproliferativediseaseretrospectivestudyof16casesandliteraturereview
AT hsevestre myelofibrosisassociatedlymphoproliferativediseaseretrospectivestudyof16casesandliteraturereview
AT jpmarolleau myelofibrosisassociatedlymphoproliferativediseaseretrospectivestudyof16casesandliteraturereview
AT gdamaj myelofibrosisassociatedlymphoproliferativediseaseretrospectivestudyof16casesandliteraturereview